Impax Shares Jump on Merger Buzz

Shares of Impax Laboratories Inc. (IPXL) soared 13.2% to $24.40 in afternoon trading on Thursday, Sept. 21, following a report by the Wall Street Journal that the drug maker is in merger discussions with closely held Amneal Pharmaceuticals LLC.

A deal could materialize next month, the report said, citing people familiar with the matter.

An Impax spokesperson said the company does not comment on rumors. An Amneal representative said the firm does not comment on rumor or innuendo.

The report came after China's Shanghai Fosun Pharmaceutical (Group) Co. Ltd. disclosed a passive 5.19% stake in Impax on Aug. 31.

Impax on Aug. 9 reported second-quarter adjusted income per share of $0.18, compared with $0.21 in the year-ago period. Revenue grew 17.1% year-over-year to $202.1 million.

More of What's Trending on TheStreet:

More from Stocks

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Will Tesla Stock Tumble 33% to $195?

Will Tesla Stock Tumble 33% to $195?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump